SCHEMBL7527418

SCHEMBL7527418

CC(=O)Nc1ccc(C(=O)NCCC(C)C)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.66
HTT P42858 1/20 0.66
RAB9A P51151 2/20 0.61
NPC1 O15118 1/20 0.61
ALDH1A1 P00352 2/20 0.61
NFKB1 P19838 1/20 0.61
KCNH2 Q12809 1/20 0.61
NAMPT P43490 8/20 0.61
POLB P06746 1/20 0.59
CYP3A4 P08684 1/20 0.59
THRB P10828 1/20 0.59
BLM P54132 1/20 0.59
ATM Q13315 1/20 0.59
PKM P14618 1/20 0.58
MAPK1 P28482 1/20 0.58
HSD17B10 Q99714 1/20 0.58
TP53 P04637 1/20 0.53
HIF1A Q16665 1/20 0.53
CACNA1B Q00975 1/20 0.53
APBA1 Q02410 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17887994 0.87 SMN1; SMN2 (0.77) SMN1; SMN2HTTRAB9ANPC1ALDH1A1
SCHEMBL13652523 0.85 RAB9A (0.58) SMN1; SMN2HTTRAB9ANPC1ALDH1A1
SCHEMBL5507897 0.84 SMN1; SMN2 (0.61) SMN1; SMN2HTTALDH1A1NFKB1KCNH2
SCHEMBL24648929 0.83 SMN1; SMN2 (0.69) SMN1; SMN2HTTRAB9ANPC1ALDH1A1
SCHEMBL5508324 0.82 ALDH1A1 (0.70) SMN1; SMN2HTTALDH1A1NFKB1KCNH2
SCHEMBL11196763 0.81 ALDH1A1 (0.64) SMN1; SMN2HTTALDH1A1NFKB1KCNH2
SCHEMBL14297350 0.80 NPC1 (0.69) SMN1; SMN2HTTRAB9ANPC1ALDH1A1
SCHEMBL6570929 0.80 SMN1; SMN2 (0.69) SMN1; SMN2HTTRAB9ANPC1ALDH1A1
SCHEMBL17301589 0.80 SMN1; SMN2 (0.69) SMN1; SMN2HTTRAB9ANPC1NAMPT
SCHEMBL15087813 0.79 NAMPT (0.60) SMN1; SMN2HTTALDH1A1NFKB1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1079820-A1 BENZAMIDE THERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 2001-03-07 EP disclosed
WO-1999059569-A1 BENZAMIDE THERAPEUTICS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 1999-11-25 WO disclosed